Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Parkinson's Disease

  Free Subscription


29.04.2024

2 Brain Res
1 Exp Neurol
1 J Neural Transm (Vienna)
12 Mov Disord
1 Nat Med
3 Neurobiol Dis
1 PLoS Biol
1 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Brain Res

  1. CANSIZ D, Unal I, Gani Surmen M, Surmen S, et al
    Gentisic acid exerts neuroprotective effects in neurotoxin-induced Parkinson's disease model in zebrafish: Cross-talk between pathways related with neurodegeneration in the gut-brain axis.
    Brain Res. 2024 Apr 19:148952. doi: 10.1016/j.brainres.2024.148952.
    PubMed         Abstract available

  2. MA LY, Jia B, Geng H, Liang J, et al
    Poly(rC)-binding protein 1 alleviates neurotoxicity in 6-OHDA-induced SH-SY5Y cells and modulates glial cells in neuroinflammation.
    Brain Res. 2024;1832:148863.
    PubMed         Abstract available


    Exp Neurol

  3. FERREIRA AFF, Ulrich H, Feng ZP, Sun HS, et al
    Neurodegeneration and glial morphological changes are both prevented by TRPM2 inhibition during the progression of a Parkinson's disease mouse model.
    Exp Neurol. 2024;377:114780.
    PubMed         Abstract available


    J Neural Transm (Vienna)

  4. PIRAMIDE N, De Micco R, Di Nardo F, Caiazzo G, et al
    Altered domain-specific striatal functional connectivity in patients with Parkinson's disease and urinary symptoms.
    J Neural Transm (Vienna). 2024 Apr 25. doi: 10.1007/s00702-024-02776.
    PubMed         Abstract available


    Mov Disord

  5. STEINA A, Sure S, Butz M, Vesper J, et al
    Mapping Subcortico-Cortical Coupling-A Comparison of Thalamic and Subthalamic Oscillations.
    Mov Disord. 2024;39:684-693.
    PubMed         Abstract available

  6. KORNILOV E, Baker Erdman H, Kahana E, Fireman S, et al
    Interleaved Propofol-Ketamine Maintains DBS Physiology and Hemodynamic Stability: A Double-Blind Randomized Controlled Trial.
    Mov Disord. 2024;39:694-705.
    PubMed         Abstract available

  7. PATEL J, Dawson VL, Dawson TM
    Blocking the Self-Destruct Program of Dopamine Neurons through Macrophage Migration Inhibitory Factor Nuclease Inhibition.
    Mov Disord. 2024;39:644-650.
    PubMed         Abstract available

  8. FREQUIN HL, Verschuur CVM, Suwijn SR, Boel JA, et al
    Long-Term Follow-Up of the LEAP Study: Early Versus Delayed Levodopa in Early Parkinson's Disease.
    Mov Disord. 2024 Apr 21. doi: 10.1002/mds.29796.
    PubMed         Abstract available

  9. KLUGE A, Schaeffer E, Bunk J, Sommerauer M, et al
    Detecting Misfolded alpha-Synuclein in Blood Years before the Diagnosis of Parkinson's Disease.
    Mov Disord. 2024 Apr 23. doi: 10.1002/mds.29766.
    PubMed         Abstract available

  10. XIE T, Warnke PC
    Comment on: "A Transatlantic Viewpoint on the Role of Pallidal Stimulation for Parkinson's Disease".
    Mov Disord. 2024;39:760-761.
    PubMed        

  11. BOOGERS A, Fasano A
    Reply to: Comment on: A Transatlantic Viewpoint on the Role of Pallidal Stimulation for Parkinson's Disease.
    Mov Disord. 2024;39:761.
    PubMed        

  12. PETERS J, Maamary J, Kyle K, Olsen N, et al
    Reply to: Recurrence of Parkinson's Disease Tremor after Focused Ultrasound Thalamotomy?
    Mov Disord. 2024;39:759-760.
    PubMed        

  13. ONDER H
    Recurrence of Parkinson's Disease Tremor after Focused Ultrasound Thalamotomy?
    Mov Disord. 2024;39:758-759.
    PubMed        

  14. SENKEVICH K, Miliukhina I, Zhuravlev A, Shumilova M, et al
    Autosomal Dominant Parkinson's Disease Caused by SNCA p.E46K Mutation in a Family with Russian Ancestry.
    Mov Disord. 2024 Apr 25. doi: 10.1002/mds.29821.
    PubMed        

  15. MONCHI O, Pinilla-Monsalve GD, Almgren H, Ghahremani M, et al
    White Matter Microstructural Underpinnings of Mild Behavioral Impairment in Parkinson's Disease.
    Mov Disord. 2024 Apr 25. doi: 10.1002/mds.29804.
    PubMed         Abstract available

  16. DODET P, Houot M, Leu-Semenescu S, Gaurav R, et al
    Isolated REM Sleep without Atonia Is Not Equivalent to REM Sleep Behavior Disorder in Early-Stage Parkinson's Disease.
    Mov Disord. 2024 Apr 26. doi: 10.1002/mds.29813.
    PubMed         Abstract available


    Nat Med

  17. MULIYIL S
    Repurposing a diabetes drug to treat Parkinson's disease.
    Nat Med. 2024 Apr 20. doi: 10.1038/d41591-024-00026.
    PubMed        


    Neurobiol Dis

  18. TREMBLAY C, Aslam S, Walker JE, Lorenzini I, et al
    RNA sequencing of olfactory bulb in Parkinson's disease reveals gene alterations associated with olfactory dysfunction.
    Neurobiol Dis. 2024 Apr 23:106514. doi: 10.1016/j.nbd.2024.106514.
    PubMed         Abstract available

  19. BUOSO C, Seifert M, Lang M, Griffith CM, et al
    Dopamine?iron homeostasis interaction rescues mitochondrial fitness in Parkinson's disease.
    Neurobiol Dis. 2024 Apr 20:106506. doi: 10.1016/j.nbd.2024.106506.
    PubMed         Abstract available

  20. TONG B, Ba Y, Li Z, Yang C, et al
    Targeting dysregulated lipid metabolism for the treatment of Alzheimer's disease and Parkinson's disease: Current advancements and future prospects.
    Neurobiol Dis. 2024 Apr 18:106505. doi: 10.1016/j.nbd.2024.106505.
    PubMed         Abstract available


    PLoS Biol

  21. WU D, Sun JK, Chow KH
    Neuronal cell cycle reentry events in the aging brain are more prevalent in neurodegeneration and lead to cellular senescence.
    PLoS Biol. 2024;22:e3002559.
    PubMed         Abstract available


    PLoS One

  22. MORACA GAG, Orcioli-Silva D, Legutke BR, Gutierrez PP, et al
    Aerobic exercise on the treadmill combined with transcranial direct current stimulation on the gait of people with Parkinson's disease: A protocol for a randomized clinical trial.
    PLoS One. 2024;19:e0300243.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.